4
Changes in Ownership
Calidi Biotherapeutics, Inc. Filed Acc 0001493152-24-022745
Director acquired 548,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schoeneck James A Director | 2024-06-03 | Option exercise | +173,000 | $0.20 | $34,600 | 588,887 | I |
| Schoeneck James A Director | 2024-06-03 | Option exercise | +375,000 | $0.20 | $75,000 | 963,887 | I |
| Derivatives | |||||||
| Schoeneck James A Director | 2024-06-03 | Option exercise · Warrants | −173,000 | 202,000 | I | ||
| Schoeneck James A Director | 2024-06-03 | Option exercise · Warrants | +173,000 | 173,000 | I | ||
| Schoeneck James A Director | 2024-06-03 | Option exercise · Warrants | −375,000 | 0 | I | ||
| Schoeneck James A Director | 2024-06-03 | Option exercise · Warrants | +375,000 | 375,000 | I | ||
| Schoeneck James A Director | 2024-06-03 | Grant or award · Warrants | +548,000 | 548,000 | I | ||
Loading xslF345X05/ownership.xml…